Science Pool

Evotec achieves key milestones in its collaboration with Bristol Myers Squibb on targeted protein degradation

Evotec SE today announced that the Company has achieved key milestones in its partnership with Bristol Myers Squibb in the field of targeted protein degradation with the first two targets transitioning into drug discovery after completing a comprehensive target validation process.
Read More